balchem corp. - BCPC

BCPC

Close Chg Chg %
170.56 -0.75 -0.44%

Open Market

169.82

-0.75 (0.44%)

Volume: 24.41K

Last Updated:

Sep 9, 2026, 10:29 AM EDT

Company Overview: balchem corp. - BCPC

BCPC Key Data

Open

$169.94

Day Range

169.05 - 170.62

52 Week Range

139.17 - 183.75

Market Cap

$5.47B

Shares Outstanding

31.88M

Public Float

31.70M

Beta

0.81

Rev. Per Employee

N/A

P/E Ratio

33.76

EPS

$5.13

Yield

56.29%

Dividend

$0.96

EX-DIVIDEND DATE

Dec 23, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

149.69K

 

BCPC Performance

1 Week
 
-0.61%
 
1 Month
 
-4.94%
 
3 Months
 
3.34%
 
1 Year
 
9.10%
 
5 Years
 
22.92%
 

BCPC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About balchem corp. - BCPC

Balchem Corp. markets specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in 1967 and is headquartered in Montvale, NJ.

BCPC At a Glance

Balchem Corp.
5 Paragon Drive
Montvale, New Jersey 07645
Phone 1-845-326-5600 Revenue 1.04B
Industry Food: Specialty/Candy Net Income 154.85M
Sector Consumer Non-Durables 2025 Sales Growth 8.753%
Fiscal Year-end 12 / 2026 Employees 1,352
View SEC Filings

BCPC Valuation

P/E Current 33.761
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 32.291
Price to Sales Ratio 4.821
Price to Book Ratio 3.91
Price to Cash Flow Ratio 23.09
Enterprise Value to EBITDA 19.377
Enterprise Value to Sales 4.923
Total Debt to Enterprise Value 0.035

BCPC Efficiency

Revenue/Employee 767,130.917
Income Per Employee 114,530.325
Receivables Turnover 7.223
Total Asset Turnover 0.626

BCPC Liquidity

Current Ratio 2.073
Quick Ratio 1.328
Cash Ratio 0.423

BCPC Profitability

Gross Margin 35.735
Operating Margin 21.051
Pretax Margin 19.19
Net Margin 14.93
Return on Assets 9.349
Return on Equity 12.864
Return on Total Capital 10.767
Return on Invested Capital 11.104

BCPC Capital Structure

Total Debt to Total Equity 14.37
Total Debt to Total Capital 12.564
Total Debt to Total Assets 10.582
Long-Term Debt to Equity 14.066
Long-Term Debt to Total Capital 12.299
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Balchem Corp. - BCPC

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
942.36M 922.44M 953.68M 1.04B
Sales Growth
+17.94% -2.11% +3.39% +8.75%
Cost of Goods Sold (COGS) incl D&A
661.91M 620.38M 617.48M 666.53M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
51.30M 54.41M 47.45M 45.19M
Depreciation
24.03M 26.37M 28.21M 28.20M
Amortization of Intangibles
27.27M 28.04M 19.24M 16.99M
COGS Growth
+19.08% -6.27% -0.47% +7.94%
Gross Income
280.45M 302.06M 336.21M 370.63M
Gross Income Growth
+15.33% +7.70% +11.31% +10.24%
Gross Profit Margin
+29.76% +32.75% +35.25% +35.74%
2022 2023 2024 2025 5-year trend
SG&A Expense
132.50M 123.95M 152.00M 152.30M
Research & Development
12.19M 15.05M 16.79M 18.51M
Other SG&A
120.30M 108.90M 135.20M 133.79M
SGA Growth
+14.99% -6.45% +22.63% +0.20%
Other Operating Expense
- - - -
-
Unusual Expense
2.77M 18.91M 1.30M 9.01M
EBIT after Unusual Expense
145.19M 159.19M 182.91M 209.33M
Non Operating Income/Expense
1.08M 1.80M 72.00K (77.00K)
Non-Operating Interest Income
- - 2.25M 1.12M
-
Equity in Earnings of Affiliates
(559.00K) (509.00K) (489.00K) (491.00K)
Interest Expense
12.52M 23.73M 16.53M 10.22M
Interest Expense Growth
+165.61% +89.58% -30.36% -38.17%
Gross Interest Expense
12.52M 23.73M 16.53M 10.22M
Interest Capitalized
- - - -
-
Pretax Income
133.75M 137.26M 166.45M 199.03M
Pretax Income Growth
+6.80% +2.63% +21.27% +19.57%
Pretax Margin
+14.19% +14.88% +17.45% +19.19%
Income Tax
28.38M 28.72M 37.98M 44.19M
Income Tax - Current - Domestic
30.39M 31.71M 34.38M 32.10M
Income Tax - Current - Foreign
7.10M 7.63M 10.38M 5.97M
Income Tax - Deferred - Domestic
(8.89M) (8.34M) (3.59M) 6.01M
Income Tax - Deferred - Foreign
(215.00K) (2.29M) (3.19M) 106.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
(559.00K) (509.00K) (489.00K) (491.00K)
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
105.37M 108.54M 128.47M 154.84M
Minority Interest Expense
- - - -
-
Net Income
105.37M 108.54M 128.47M 154.84M
Net Income Growth
+9.64% +3.01% +18.36% +20.53%
Net Margin Growth
+11.18% +11.77% +13.47% +14.93%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
105.37M 108.54M 128.47M 154.84M
Preferred Dividends
- - - -
-
Net Income Available to Common
105.37M 108.54M 128.47M 154.84M
EPS (Basic)
3.2908 3.3806 3.9736 4.7992
EPS (Basic) Growth
+10.31% +2.73% +17.54% +20.78%
Basic Shares Outstanding
32.02M 32.11M 32.33M 32.27M
EPS (Diluted)
3.2528 3.3451 3.9267 4.7493
EPS (Diluted) Growth
+10.58% +2.84% +17.39% +20.95%
Diluted Shares Outstanding
32.39M 32.45M 32.72M 32.60M
EBITDA
199.26M 232.51M 231.66M 263.52M
EBITDA Growth
+14.71% +16.69% -0.36% +13.75%
EBITDA Margin
+21.14% +25.21% +24.29% +25.41%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 209.00
Number of Ratings 4 Current Quarters Estimate 1.43
FY Report Date 09 / 2026 Current Year's Estimate 5.403
Last Quarter’s Earnings 1.39 Median PE on CY Estimate N/A
Year Ago Earnings 4.75 Next Fiscal Year Estimate 5.63
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 3 3
Mean Estimate 1.43 1.38 5.40 5.63
High Estimates 1.45 1.39 5.44 5.90
Low Estimate 1.41 1.36 5.34 5.43
Coefficient of Variance 1.98 1.54 1.02 4.31

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 3
OVERWEIGHT 1 1 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Balchem Corp. in the News